Long and short echo time proton magnetic resonance spectroscopic imaging of the healthy aging brain

Journal of Magnetic Resonance Imaging

Volumn 26, Issue 6, 2007, Pages 1596-1606

  McIntyre, Dominick J O ^a,b   Charlton, Rebecca A ^a   Markus, Hugh S ^a   Howe, Franklyn A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Aging; Human brain; In vivo; Magnetic resonance spectroscopy; Spectroscopic imaging

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; ECHO PLANAR IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

AGED; AGED, 80 AND OVER; AGING; ARTIFACTS; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; DIPEPTIDES; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS;

EID: 37349023617     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21198     Document Type: Article

References (40)

1. West MJ. New stereological methods for counting neurons. Neurobiol Aging 1993;14:275-285.
2. Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science 1997;278:412-419.
3. Filippi M, Rocca MA, Comi G. The use of quantitative magnetic-resonance- based techniques to monitor the evolution of multiple sclerosis. Lancet Neurol 2003;2:337-346.
4. Sarchielli P, Presciutti O, Pelliccioli GP, et al. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain 1999;122:513-521.
5. Kadota T, Horinouchi T, Kuroda C. Development and aging of the cerebrum: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 2001;22:128-135.
6. Angelie E, Bonmartin A, Boudraa A, Gonnaud PM, Mallet JJ, Sappey-Marinier D. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. AJNR Am J Neuroradiol 2001;22:119-127.
7. Chang L, Ernst T, Poland RE, Jenden DJ. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci 1996;58:2049-2056.
8. Brooks JCW, Roberts TP, Kemp GJ, Gosney MA, Lye M, Whitehouse GJ. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex 2001;11:598-605.
9. Leary SM, Brex PA, MacManus DG, et al. A H-1 magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Imaging 2000;18:455-459.
10. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med 1999;41:276-284.
11. Baslow MH. Functions of N-acetyl-L-aspartate and N-acetyl-L- aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J Neurochem 2000;75:453-459.
12. Baslow MH. N-Acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 2003;28:941-953.
13. Neale JH, Bzdega T, Wroblewska B. N-acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 2000;75:443-452.
14. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imaging 1999;9:711-716.
15. Sijens PE, den Heijer T, de Leeuw FE, et al. MR spectroscopy detection of lactate and lipid signals in the brains of healthy elderly people. Eur Radiol 2001;11:1495-1501.
16. Kreis R, Slotboom J, Hofmann L, Boesch C. Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects. Magn Reson Med 2005;54:761-768.
17. Charlton RA, Barrick TR, McIntyre DJ, et al. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 2006;66:217-222.
18. Tombaugh TN, McIntyre NJ. The Mini Mental State Examination - a comprehensive review. J Am Geriatr Soc 1992;40:922-935.
19. Charlton RA, Landau S, Schiavone F, et al. A structural equation modeling investigation of age-related variance in executive function and DTI measured white matter damage. Neurobiol Aging 2007, doi:10.1016/j.neurobiolaging.2007.03. 017.
20. O'Connor DW, Pollitt PA, Hyde JB, et al. The reliability and validity of the mini-mental state in a British-community survey. J Psychiatr Res 1989;23:87-96.
21. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11:805-821.
22. Provencher SW. Estimation of metabolite concentrations from localized in-vivo proton NMR-spectra. Magn Reson Med 1993;30:672-679.
23. Provencher SW. Automatic quantitation of localized in vivo H-1 spectra with LCModel. NMR Biomed 2001;14:260-264.
24. McLean MA, Woermann FG, Barker GJ, Duncan JS. Quantitative analysis of short echo time H-1-MRSI of cerebral gray and white matter. Magn Reson Med 2000;44:401-411.
25. Wild JM, Marshall I. Normalisation of metabolite images in H-1 NMR spectroscopic imaging. Magn Reson Imaging 1997;15:1057-1066.
26. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
27. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 1997;16:2529-2542.
28. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
29. McKnight TR, Noworolski SM, Vigneron DB, Nelson SJ. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imaging 2001;13:167-177.
30. van der Knaap MS, van der Grond J, van Rijen PC, Faber JA, Valk J, Willemse K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176:509-515.
31. Longo R, Ricci C, Dalla Palma L, et al. Quantitative P-31 MRS of the normal adult human brain - assessment of interindividual differences and aging effect. NMR Biomed 1993;6:53-57.
32. Smith CD, Pettigrew LC, Avison MJ, et al. Frontal-lobe phosphorus-metabolism and neuropsychological function in aging and in Alzheimer's disease. Ann Neurol 1995;38:194-201.
33. Smith CD, Landrum W, Carney JM, Landfield PW, Avison MJ. Brain creatine kinase with aging in F-344 rats: analysis by saturation transfer magnetic resonance spectroscopy. Neurobiol Aging 1997;18:617-622.
34. Saunders DE, Howe FA, van den Boogaart A, McLean MA, Griffiths JR, Brown MM. Continuing ischemic damage after acute middle cerebral-artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 1995;26:1007-1013.
35. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
36. Hofmann L, Slotboom J, Boesch C, Kreis R. Characterization of the macromolecule baseline in localized H-1-MR spectra of human brain. Magn Reson Med 2001;46:855-863.
37. Mader I, Seeger U, Karitzky J, Erb M, Schick F, Klose U. Proton magnetic resonance spectroscopy with metabolite nulling reveals regional differences of macromolecules in normal human brain. J Magn Reson Imaging 2002;16:538-546.
38. Chen SS, Shao KN, Chiang JH, et al. Fat in the cerebral falx. Zhonghua Yi Xue Za Zhi (Taipei) 2000;63:804-808.
39. Lee DH, Larson TC, III, Norman D. Falx ossification - MR visualization. Can Assoc Radiol J 1988;39:260-262.
40. Sands SF, Farmer P, Alvarez O, Keller IA, Gorey MT, Hyman RA. Fat within the falx: MR demonstration of falcine bony metaplasia with marrow formation. J Comput Assist Tomogr 1987;11:602-605.